Loading...
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report
BACKGROUND: Clear cell sarcoma (CCS), initially named malignant melanoma of soft parts, is an aggressive soft tissue sarcoma (STS) that, due to MITF activation, shares with melanoma the expression of melanocyte differentiation antigens. CCS is poorly sensitive to chemotherapy. Multi-kinase inhibitor...
Saved in:
| Published in: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4342079/ https://ncbi.nlm.nih.gov/pubmed/25880253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1044-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|